Tag: texas

Astellas Pharma, MD Anderson sign option agreement to research and develop new treatment for AML

| April 6, 2015 | 0 Comments

Astellas Pharma Inc. and The University of Texas MD Anderson Cancer Center today announced the signing of an option agreement to research and develop a new treatment for patients with acute myeloid leukemia (AML).

Continue Reading

MD Anderson, Astellas Pharma Sign Option Agreement

| April 3, 2015 | 0 Comments

The University of Texas MD Anderson Cancer Center and Astellas Pharma Inc.

Continue Reading

Livestrong charity announces new CEO for post-Armstrong era

| March 25, 2015 | 0 Comments

AUSTIN, Texas (AP) — Cancer-fighting charity Livestrong has named a new CEO as the foundation continues to dig out from the performance-enhancing drug use scandal of founder Lance Armstrong.

Continue Reading

Jim Allison wins 2015 Paul Ehrlich and Ludwig Darmstaedter Prize

| March 16, 2015 | 0 Comments

( University of Texas M. D. Anderson Cancer Center ) Jim Allison, Ph.D., chair of Immunology at the University of Texas MD Anderson Cancer Center, received the 2015 Paul Ehrlich and Ludwig Darmstaedter Prize Saturday in recognition of his work opening a completely new way to treat cancer.

Continue Reading

President of MD Anderson selected as new fellow of AACR Academy

| March 8, 2015 | 0 Comments

Ron DePinho, M.D., president of The University of Texas MD Anderson Cancer Center, will be inducted as a new fellow of the American Association for Cancer Research Academy. He joins 10 other cancer leaders in the prestigious academy that recognizes people who have made significant contributions to cancer research.

Continue Reading

MD Anderson President Named as Fellow of Top Cancer Research Group

| February 18, 2015 | 0 Comments

Ron DePinho, M.D., president of The University of Texas MD Anderson Cancer Center, will be inducted as a new fellow of the American Association for Cancer Research (AACR) Academy.

Continue Reading

Lenvatinib Shows Promise for Patients with Radioiodine-Refractory Thyroid Cancer

| February 11, 2015 | 0 Comments

In a pivotal Phase III study led by researchers at The University of Texas MD Anderson Cancer Center, the oral anti-angiogenic therapy lenvatinib has shown dramatic improvement in progression-free survival in patients with advanced radioiodine-refractory thyroid cancer.

Continue Reading

Former Charger girl loses battle to cancer

| January 27, 2015 | 0 Comments

SAN DIEGO – Former Charger girl, Lyly Koenig-Mendez, lost her battle to breast cancer on January 20, 2015 in Houston, Texas. “After hearing the bad news of not being able to treat her for the breast cancer which had metastasized to her liver and had spread… we decided it was best to spend the rest […]

Continue Reading

Bayer, MD Anderson partner to evaluate how a drug may affect patient's disease-related symptoms

| January 24, 2015 | 0 Comments

When cancer patients take part in a clinical trial to develop new therapies, they and their physicians want to know how they will feel and function during treatment.

Continue Reading

Bayer, MD Anderson partner to evaluate how a drug may affect patient's disease-related symptoms

| January 24, 2015 | 0 Comments

When cancer patients take part in a clinical trial to develop new therapies, they and their physicians want to know how they will feel and function during treatment. A new collaboration between Bayer and The University of Texas MD Anderson Cancer Center will go straight to the patients to learn how certain investigational new drugs affect them.

Continue Reading